BackScribe Therapeutics Overview

Scribe Therapeutics Total Current Liabilities

Track Scribe Therapeutics's total current liabilities ($38M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$37.93M

Peer trimmed avg / median

Loading

Scribe Therapeutics Total Current Liabilities History

Loading

Scribe Therapeutics vs. peers: Total Current Liabilities Comparison

Loading

Scribe Therapeutics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Scribe Therapeutics (SCTX) FAQ

The latest total current liabilities for SCTX is $38M as of September 2026. Investors often review this figure alongside Scribe Therapeutics's historical trend and sector peers before judging valuation or financial health.

A total current liabilities figure of $38M for SCTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SCTX's total current liabilities ($38M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Scribe Therapeutics's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers